Page last updated: 2024-08-17

androstenedione and oxadiazoles

androstenedione has been researched along with oxadiazoles in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Auchus, RJ; Chan, JL; Davis, SM; Farber, RH; Fechner, PY; Giri, N; Imel, EA; Roberts, E; Sarafoglou, K; Sturgeon, J; Vogiatzi, MG	1

Trials

1 trial(s) available for androstenedione and oxadiazoles

Article	Year
Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia. The Journal of clinical endocrinology and metabolism, 2022, 02-17, Volume: 107, Issue:3 Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androstenedione; Azabicyclo Compounds; Biomarkers; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Oxadiazoles; Receptors, Corticotropin-Releasing Hormone; Testosterone; Treatment Outcome; Young Adult	2022

Article

Year

Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.

The Journal of clinical endocrinology and metabolism, 2022, 02-17, Volume: 107, Issue:3

Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androstenedione; Azabicyclo Compounds; Biomarkers; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Oxadiazoles; Receptors, Corticotropin-Releasing Hormone; Testosterone; Treatment Outcome; Young Adult

2022